Home » FDA Gives Generic-Drug Makers a QbD Example for Modified-Release Drugs
FDA Gives Generic-Drug Makers a QbD Example for Modified-Release Drugs
The FDA is encouraging generic-drug makers to use quality by design (QbD) for modified-release products by publishing an example of the development, design and manufacturing of a fictitious modified-release drug using QbD principles.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May